Many risk factors for diabetic neuropathy have been identified, including the presence of cardiovascular risk factors [14] and studies have aimed to determine the possible benefit of GLP-1 RAs in the prevention or improvement of peripheral neuropathy. This evidence concerns the gene GLP1R and peripheral neuropathy.